These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15621220)

  • 1. Defining overactive bladder: epidemiology and burden of disease.
    Tubaro A
    Urology; 2004 Dec; 64(6 Suppl 1):2-6. PubMed ID: 15621220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and burden of overactive bladder in the United States.
    Stewart WF; Van Rooyen JB; Cundiff GW; Abrams P; Herzog AR; Corey R; Hunt TL; Wein AJ
    World J Urol; 2003 May; 20(6):327-36. PubMed ID: 12811491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the effect of overactive bladder symptoms on woman's quality of life during and after first pregnancy?
    Van Brummen HJ; Bruinse HW; Van de Pol G; Heintz AP; Van der Vaart CH
    BJU Int; 2006 Feb; 97(2):296-300. PubMed ID: 16430633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The overactive bladder and quality of life.
    Epstein LB; Goldberg RP
    Int J Fertil Womens Med; 2005; 50(1):30-6. PubMed ID: 15971719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The patient's perspective: redefining end points.
    Palmtag H
    Urology; 2004 Dec; 64(6 Suppl 1):17-20. PubMed ID: 15621223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related consequences of overactive bladder.
    Wagner TH; Hu TW; Bentkover J; LeBlanc K; Stewart W; Corey R; Zhou Z; Hunt T
    Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruptive effects of overactive bladder and urge urinary incontinence in younger women.
    Sand PK; Appell R
    Am J Med; 2006 Mar; 119(3 Suppl 1):16-23. PubMed ID: 16483864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of urinary incontinence and overactive bladder in the United States: a comparative study.
    Hu TW; Wagner TH; Bentkover JD; Leblanc K; Zhou SZ; Hunt T
    Urology; 2004 Mar; 63(3):461-5. PubMed ID: 15028438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of overactive bladder.
    Milsom I; Stewart W; Thüroff J
    Am J Manag Care; 2000 Jul; 6(11 Suppl):S565-73. PubMed ID: 11183899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of overactive bladder and incontinence in Canada.
    Corcos J; Schick E
    Can J Urol; 2004 Jun; 11(3):2278-84. PubMed ID: 15287994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of overactive bladder syndrome on the sexual quality of life in Korean young and middle aged women.
    Kim YH; Seo JT; Yoon H
    Int J Impot Res; 2005; 17(2):158-63. PubMed ID: 15510187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The wet patient: understanding patients with overactive bladder and incontinence.
    Serels S
    Curr Med Res Opin; 2004 Jun; 20(6):791-801. PubMed ID: 15200735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of the overactive bladder syndrome by applying the International Continence Society definition.
    Temml C; Heidler S; Ponholzer A; Madersbacher S
    Eur Urol; 2005 Oct; 48(4):622-7. PubMed ID: 15964133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women.
    Teleman PM; Lidfeldt J; Nerbrand C; Samsioe G; Mattiasson A;
    BJOG; 2004 Jun; 111(6):600-4. PubMed ID: 15198789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactive bladder: prevalence and implications in Brazil.
    Teloken C; Caraver F; Weber FA; Teloken PE; Moraes JF; Sogari PR; Graziottin TM
    Eur Urol; 2006 Jun; 49(6):1087-92. PubMed ID: 16497431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the overactive bladder in women and men.
    Kowalczyk J
    J Gend Specif Med; 2003; 6(4):25-9. PubMed ID: 14714447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.